Shout out to clients Rust Felix & Michael Felix who have brought Slope from an idea to closing their $20M Series A with one of the world's leading VC's. Two amazing Co-Founders and people.
It's been an honor supporting Rust & Michael as they worked through early product-market fit challenges, built their operational chops, crossed through the trough of sorrows and now are poised to revolutionize the clinical trials industry.
Slope, the clinical operations solution company, today announced the closing of a $20 million Series A financing, led by global venture capital firm New Enterprise Associates, Inc. (NEA), to accelerate go-to-market efforts and further expand into decentralized and direct-to-patient clinical trials. Slope’s technology-driven infrastructure solution connects all clinical trial stakeholders—ClinOps teams, CROs, research sites, patients, vendors, and laboratories—in real-time through a 21 CFR Part 11 compliant software platform, capturing clinical supply chain demand data at the patient level and then using it alongside research-specific workflows to orchestrate and automate operational complexity.